Metabolic DiseaseNuLifeNCT05930717
Zhejiang Nutrition and Health Study
An observational study of Metabolic Disease and Cardiovascular Diseases, run by Westlake University at 2 sites in China.
Trial summary
This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province. The cohort will include individuals in a wide range of age groups. Read more about this study
- Who is it for?
- Ages 6 years and olderHealthy volunteers can take part
- Conditions the study is for
- Metabolic Disease, Cardiovascular Diseases, Healthy Aging
- How many people
- 0 participants
- Where
- 2 sitesChina
- Study dates
- 19 Jul 2023to Jul 2033
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Permanent residents in Zhejiang Province
Who may be able to join
- Chinese citizens who have resided in the surveyed area for at least 6 months before the survey within the last 12 months.
- Aged 6 years or older.
- They are included as resident households, which are comprised of people living together in one place based on family relationships, and at least one resident with permanent household registration.
Who cannot join
- Residents living in functional zones such as construction worker dormitories, military barracks, schools, nursing homes, etc.
Trial locations and contacts
2 sites in 1 country.
China2 sites
Zhejiang Provincial Center for Disease Control and Prevention
Hangzhou, Zhejiang, 310052
Westlake University
Hangzhou, Zhejiang
About this study
Official title: Zhejiang Nutrition and Health Study: Nutrition and Lifespan Study (NuLife Study)
This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province. The cohort will include individuals in a wide range of age groups. The demographic, diet, lifestyle information, health status, and corresponding bio-samples will be collected carefully. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to evidence-based nutrition interventions to improve health outcomes and enhance quality of life.
Read the detailed description
This project aims to elucidate the relationship between healthy lifespan and nutrition through the establishment of a large-scale cohort of participants and longitudinal follow-ups spanning around 10 years in Zhejiang Province. The cohort will comprise individuals in a wide range of age groups starting at 6 years old. The participants will provide demographic information, anthropometry measurements, detailed diet, lifestyle data and health status, including 3-day dietary records and long-term food intake frequency recalls. Integrated with previous information, diverse bio-samples will also be collected to establish a multi-dimensional biobank. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to the development of evidence-based nutrition designed to improve health outcomes and enhance the quality of life for individuals of all ages.
- Conditions
- Metabolic Disease, Cardiovascular Diseases, Healthy Aging
- Keywords
- Nutrition, Health, Healthy lifespan
- Medical subject headings
- Metabolic Diseases, Cardiovascular Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurrence of cardio-metabolic diseases
The investigators will track for occurrence of cardio-metabolic diseases by follow-up surveys collected by the Zhejiang Center for Disease Control and Prevention.
Measured: up to 10 years
Secondary outcomes (7)
Changes in fasting blood glucose
Fasting glucose will be examined in mmol/L.
Measured: Every other year, up to 10 years
Changes in fasting blood HbA1c
Fasting blood HbA1c will be examined in %
Measured: Every other year, up to 10 years
Changes in fasting lipid metabolism
Triglyceride, cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol will be examined in mmol/L.
Measured: Every other year, up to 10 years
Changes in fasting blood highly sensitive C-reactive protein (CRP)
CRP will be examined in mg/L.
Measured: Every other year, up to 10 years
Changes in body mass index
Body mass index (BMI) will be calculated in kg/m^2
Measured: Every other year, up to 10 years
Changes in blood pressure
Blood pressure, including systolic and diastolic blood pressure, will be measured in mmHg
Measured: Every other year, up to 10 years
Changes in gut microbiome profiling
16S rRNA and/or shotgun metagenomic sequencing will be performed in stool samples.
Measured: Every other year, up to 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jul 2023
- Study start19 Jul 2023
- Primary completionJul 2033 (estimated)
- Study completionJul 2033 (estimated)
Why it stopped: The research has been withdrawn due to funding limitations.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Westlake University
- Sponsor type
- University, hospital or other
- Collaborators
- Zhejiang Provincial Center for Disease Control and Prevention
- Responsible party
- Sponsor
- Investigators
- Ju-Sheng Zheng, PhD, Principal investigator, Westlake University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05930717
- Sponsor's protocol ID
- 20230511JZS001
- Acronym
- NuLife
- Status last verified
- May 2025
- First submitted
- 26 Jun 2023
- Last updated
- 13 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Zhejiang Nutrition and Health Study: Nutrition and Lifespan Study (NuLife Study)
- ClinicalTrials.gov ID
- NCT05930717
- Acronym / sponsor ID
- NuLife / 20230511JZS001
- Conditions
- Metabolic Disease, Cardiovascular Diseases, Healthy Aging
- Keywords
- Nutrition, Health, Healthy lifespan
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: The research has been withdrawn due to funding limitations.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Westlake UniversityUniversity, hospital or other
- Collaborators
- Zhejiang Provincial Center for Disease Control and Prevention
- Study start
- 19 Jul 2023 (actual)
- Primary completion
- Jul 2033 (estimated)
- Study completion
- Jul 2033 (estimated)
- First posted
- 5 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province. The cohort will include individuals in a wide range of age groups. The demographic, diet, lifestyle information, health status, and corresponding bio-samples will be collected carefully. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to evidence-based nutrition interventions to improve health outcomes and enhance quality of life.
Detailed description
This project aims to elucidate the relationship between healthy lifespan and nutrition through the establishment of a large-scale cohort of participants and longitudinal follow-ups spanning around 10 years in Zhejiang Province. The cohort will comprise individuals in a wide range of age groups starting at 6 years old. The participants will provide demographic information, anthropometry measurements, detailed diet, lifestyle data and health status, including 3-day dietary records and long-term food intake frequency recalls. Integrated with previous information, diverse bio-samples will also be collected to establish a multi-dimensional biobank. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to the development of evidence-based nutrition designed to improve health outcomes and enhance the quality of life for individuals of all ages.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 6 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Permanent residents in Zhejiang Province
Key inclusion criteria (3 listed)
- Chinese citizens who have resided in the surveyed area for at least 6 months before the survey within the last 12 months.
- Aged 6 years or older.
- They are included as resident households, which are comprised of people living together in one place based on family relationships, and at least one resident with permanent household registration.
Key exclusion criteria (1 listed)
- Residents living in functional zones such as construction worker dormitories, military barracks, schools, nursing homes, etc.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Occurrence of cardio-metabolic diseases
Time frame: up to 10 years
The investigators will track for occurrence of cardio-metabolic diseases by follow-up surveys collected by the Zhejiang Center for Disease Control and Prevention.
7 secondary outcomes
Changes in fasting blood glucose
Time frame: Every other year, up to 10 years
Changes in fasting blood HbA1c
Time frame: Every other year, up to 10 years
Changes in fasting lipid metabolism
Time frame: Every other year, up to 10 years
Changes in fasting blood highly sensitive C-reactive protein (CRP)
Time frame: Every other year, up to 10 years
Changes in body mass index
Time frame: Every other year, up to 10 years
Changes in blood pressure
Time frame: Every other year, up to 10 years
Changes in gut microbiome profiling
Time frame: Every other year, up to 10 years
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2025.
Related trials for Metabolic Disease
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Not yet recruitingObservational study
Periodontal Status and Biomarkers in MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ju-Sheng Zheng, PhD principal investigator
Westlake University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Metabolic Disease and Cardiovascular Diseases, run by Westlake University at 2 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurrence of cardio-metabolic diseases (time frame: up to 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.